Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
4550 participants
OBSERVATIONAL
2021-01-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Canadian Health Economics, Outcome, and Effectiveness Comparison of Treatment in Patients With Chronic Rhinosinusitis
NCT01455948
Global Sinus Surgery Registry
NCT02347943
The German National CRS Registry (GenreCRS): Clinical Evaluation of the New European Academy for Allergy and Clinical Immunology (EAACI) Criteria for CRSwNP Disease Control, Remission and Cure in a Real-World Evidence Study Approach
NCT06815211
NEUROMARK Registry Study
NCT05937308
Microarray Analysis of Sinus Samples From Patients With and Without Chronic Rhinosinusitis.
NCT00847041
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
As primary aim it intends to provide new insights on the burden of uncontrolled disease, the impact on health-related quality of life, productivity loss as well as the effect of disease severity and co-morbid disease on these outcome parameters.
In addition this outcome registry intends to identify patients eligible for type 2 targeted biologic therapy, evaluate treatment effectiveness and markers of treatment response.
Beyond that direct and indirect costs for society related to chronic rhinosinusitis and its' treatment will be studied.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Chronic rhinosinusitis patients
Adult chronic rhinosinusitis patients capable of using a mobile application.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Capable of using a mobile application on a smartphone
Exclusion Criteria
* Patients with inverted papilloma
* Patients with unilateral disease
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Change Accelerator in Respiratory Care
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sven F Seys, PhD
Role: STUDY_DIRECTOR
Change Accelerator in Respiratory Care
Claus Bachert, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
UZ Ghent
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Graz University Hospital
Graz, , Austria
University Hospital Vienna
Vienna, , Austria
UCL Saint-Luc
Brussels, , Belgium
UZ Ghent
Ghent, , Belgium
UZ Leuven
Leuven, , Belgium
Odense University Hospital
Odense, , Denmark
Helsinki University Hospital
Helsinki, , Finland
CHU Lille
Lille, , France
Dusseldorf University Clinic
Düsseldorf, , Germany
Policlinico Umberto I
Rome, , Italy
UMC Amsterdam
Amsterdam, , Netherlands
Hospital Clinic de Barcelona
Barcelona, , Spain
Prof Claire Hopkins private practice
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Peter-Valentin Tomazic, MD, PhD
Role: primary
Sven Schneider, MD
Role: primary
Sophie Bellemont
Role: primary
Anette Kjeldsen, MD, PhD
Role: primary
Anu Laulajainen-Hongisto, MD, PhD
Role: primary
Geoffrey Mortuaire, MD
Role: primary
Martin Wagenmann, MD, PhD
Role: primary
Carlo Cavaliere, MD
Role: primary
Sietze Reitsma, MD, PhD
Role: primary
Camilo Rodriguez, MD
Role: primary
Claire Hopkins, MD, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GHOR001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.